Injectable hydrogel with dual-sensitive behavior for targeted delivery of oncostatin M to improve cardiac restoration after myocardial infarction

Currently MI repair approaches always exhibit low efficiency and do not match the clinical requirements. To provide an advanced engineering platform, an injectable hydrogel was developed to release OSM continuously and localized in the MI lesion.